Sunday, March 22, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
  • Surveys

    Surveys

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    March 17, 2026
    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    March 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
  • Surveys

    Surveys

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    March 17, 2026
    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    March 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Politics & Law

As Overdoses Soar, More States Decriminalize Fentanyl Testing Strips

Kaiser Health News by Kaiser Health News
April 3, 2024
in Politics & Law
0
As Overdoses Soar, More States Decriminalize Fentanyl Testing Strips

As Overdoses Soar, More States Decriminalize Fentanyl Testing Strips

Andy Miller

May 5, 2022

With time running out in the 2022 legislative session, Georgia lawmakers took up a bill to regulate raw milk.

An amendment suddenly got tacked onto the House version of the bill, although the new wording had nothing to do with dairy. The language called for legalizing the use of strips that test drugs for fentanyl, a potent synthetic opioid fueling a wave of fatal overdoses across Georgia and the U.S.

The amendment, said Sen. Jen Jordan, an Atlanta Democrat who sponsored it, was “a commonsense solution to save lives.”

The revised milk bill passed overwhelmingly on the last day of the General Assembly session. If the bill doesn’t draw a veto from Republican Gov. Brian Kemp, Georgia will join a growing list of states decriminalizing the use of fentanyl testing strips as the drug’s scourge has spread across the nation.

Governors in New Mexico and Wisconsin this year signed bills allowing test strips in those states, and legislatures in Tennessee and Alabama recently passed similar legislation. In Pennsylvania, although a state law prohibits test strips, the mayors of Philadelphia and Pittsburgh have ordered bans on prosecuting people possessing them. The state’s attorney general said he won’t charge people for having the test strips. Alaska state health officials, horrified by a surge of overdose deaths, have started giving out free test strips. A vending machine in Ohio offers the fentanyl-detecting devices alongside naloxone, a medication for reversing overdoses.

But the Florida legislature balked this year at a bill that would decriminalize the testing strips. Fentanyl test devices — prohibited under drug paraphernalia laws adopted decades ago — remain illegal in about half of states, drug policy experts say.

Many public health and addiction experts, though, promote the rapid testing devices as what’s known as a “harm reduction” tactic to help prevent overdose deaths from illicit drugs that users may not know are laced with fentanyl.

“We hope all the states would come to realize the dangers of contamination are so high and that fentanyl test strips empower a person taking drugs to know whether they have fentanyl,” said Dr. Nora Volkow, director of the National Institute on Drug Abuse at the National Institutes of Health.

Street versions of fentanyl, an approved painkiller that’s being produced illegally, largely come into the U.S. from Mexico. Fentanyl is up to 100 times as powerful as morphine. It is commonly found in what is sold as heroin — often taking its place entirely. It also can be mixed into cocaine, methamphetamine, and counterfeit street pills sold as opioid medications — substances that many buyers are not expecting to contain fentanyl.

The spread of fentanyl has helped lead to a stunning rise in drug overdose deaths. Synthetic opioids — including fentanyl — were involved in about two-thirds of U.S. drug overdose deaths in the 12-month period that ended in November 2021. And three-quarters of overdose deaths from cocaine last year were associated with fentanyl, Volkow said.

“Fentanyl is so potent that it can stop your breathing at very low doses,” she said.

The fentanyl epidemic also “has exacerbated racial inequities,” Volkow added. From 2019 to 2021, fentanyl overdose deaths more than tripled among teenagers — and surged fivefold among Black teens, according to an analysis of Centers for Disease Control and Prevention data produced by the advocacy group Families Against Fentanyl.

Last month, the Drug Enforcement Administration sent a letter to federal, state, and local law enforcement officials warning of a nationwide spike in fentanyl-related mass-overdose events. “Fentanyl is killing Americans at an unprecedented rate,” said DEA Administrator Anne Milgram. “Already this year, numerous mass-overdose events have resulted in dozens of overdoses and deaths.”

The testing strips are inexpensive, costing about $1. A drug user can take a small quantity of the substance, add water, and dip a strip briefly into the solution. If one red stripe appears on the strip, fentanyl is present; two stripes mean none of that drug is found.

A downside is that the test strips don’t gauge the amount of fentanyl in the drug.

Still, the strips are effective in detecting “very small amounts of fentanyl,” said Brown University epidemiologist Brandon Marshall, part of a team that has studied illicit drug users and the devices in Rhode Island. Many of the participants who tried the strips, Marshall said, discarded the substance if fentanyl was present, used the drug with someone else present, or had naloxone available during use.

A similar study of North Carolina intravenous drug users found 3 in 4 people indicated that fentanyl strips made them feel better able to protect themselves from overdose.

In South Carolina, which has made fentanyl test strips available, the state sends an anonymous survey to anyone who receives them. Sara Goldsby, director of the South Carolina Department of Alcohol and Other Drug Abuse Services, said survey responses indicate that people who use the strips report using fewer drugs, with some choosing not to use the drugs altogether, and that they feel safer in preventing overdoses.

The testing strips, Brown’s Marshall added, “are not going to be a silver bullet to address the overdose crisis, but they can be an important tool to help people stay safe.”

In Georgia, where the testing bill awaits the governor’s approval, public health officials said fentanyl-related overdose deaths jumped after the start of the covid-19 pandemic, doubling between May 1, 2020, and April 30, 2021, compared with the same span in 2019 and 2020.

And fentanyl-related overdoses recently spiked in Savannah, Georgia, according to Dr. Jay Goldstein, medical director of the emergency department at Memorial Health. He said that many overdose patients said they were surprised at the potency of the drug they had consumed, but he fears that giving them strips won’t stem its use.

“Sad to say, but some users want fentanyl in their drugs because it gives them a more intense high, though the risk of crashing and burning is much worse,” he said.

Current drug paraphernalia laws may discourage states or organizations from applying for grants to buy test strips or creating programs to distribute them, said Jon Woodruff, senior legislative attorney for the Legislative Analysis and Public Policy Association. But in many states that haven’t decriminalized the strips, people who possess the papers aren’t being prosecuted.

In Georgia, “people can be charged, but it’s generally not prosecuted, particularly if it’s these testing strips,” said Pete Skandalakis, executive director of the Prosecuting Attorneys’ Council of Georgia, which supported the testing strips amendment.

Despite the current Georgia prohibition, the Atlanta Harm Reduction Coalition organization said it distributes the strips to individual drug users and other community members.

Meanwhile, families in Georgia who have seen loved ones die from fentanyl overdoses support making the testing strips more available.

Doreen Barr of Fayette County in suburban Atlanta lost a son to a combination dose of heroin and fentanyl seven years ago. She has set up a nonprofit foundation in Ryan Barr’s name to educate people about addiction.

Barr said she believes testing strips can save lives.

“Why not have the fentanyl strips?” she said. “Cocaine or a fake pill can have fentanyl in it. One time could kill you. If they had a test strip, maybe they wouldn’t take it.”

KHN South Carolina correspondent Lauren Sausser contributed to this article.

KHN (Kaiser Health News) is a national newsroom that produces in-depth journalism about health issues. Together with Policy Analysis and Polling, KHN is one of the three major operating programs at KFF (Kaiser Family Foundation). KFF is an endowed nonprofit organization providing information on health issues to the nation.

USE OUR CONTENT

This story can be republished for free (details).

KHN (Kaiser Health News) is a national newsroom that produces in-depth journalism about health issues. Together with Policy Analysis and Polling, KHN is one of the three major operating programs at KFF (Kaiser Family Foundation). KFF is an endowed nonprofit organization providing information on health issues to the nation.

Subscribe to KHN’s free Morning Briefing.

ShareTweet
Kaiser Health News

Kaiser Health News

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

This episode explores deceptive pricing strategies in the GLP-1 medication market, highlighting how healthcare consumerism influences patient decisions and how to recognize and protect against misleading practices.

 key  topics

Deceptive pricing strategies in healthcare
The role of brand perception and pricing manipulation
The concept of drip pricing and hidden costs
The rise of healthcare consumerism and patient agency
Strategies for patients to identify and avoid deceptive practices

Chapters

00:00 The Evolution of the GLP-1 Telemedicine Market
01:12 How Pricing Is Obscured and Perceived Discounts Are Created
02:11 TrumpRx: Coupon Aggregator or Discount Store?
03:12 Why Price Deception Thrives in Healthcare
04:12 The Membership Fee Illusion and Hidden Costs
05:10 Brand Recognition and Drip Pricing Strategies
06:17 The Impact of Brand and Anchor Pricing on Perceived Value
07:16 The Role of Price Drip Strategies in Healthcare Pricing
08:15 The Rise of Healthcare Consumerism and Patient Agency
09:14 How to Protect Yourself from Deceptive Pricing Practices
10:09 Conclusion: Empowering Patients in a Complex Pricing Landscape
Unmasking Deceptive Pricing in Healthcare: What Patients Need to Know
YouTube Video zZgo1nLZVrY
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

GLP-1 Drugs Have Moved Past Weight Loss. Medicine Has Not Fully Caught Up.

Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence

by Daily Remedy
March 1, 2026
0

Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • The Grey Market of Weight Loss: How Compounded GLP-1 Medications Continue Despite FDA Crackdowns

    The Grey Market of Weight Loss: How Compounded GLP-1 Medications Continue Despite FDA Crackdowns

    0 shares
    Share 0 Tweet 0
  • A Call to Action for Pain Patients and Advocates

    1 shares
    Share 0 Tweet 0
  • Healthcare’s Logistics Push

    0 shares
    Share 0 Tweet 0
  • Retatrutide and the Acceleration of Metabolic Medicine

    0 shares
    Share 0 Tweet 0
  • Rural Healthcare

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy